# Unichem Laboratories Ltd (UNICHEMLAB)
> Exchange: NSE | Sector: Pharma | ISIN: INE351A01035

## Price
Current Price: ₹367.15
Day Change: -1.57%
52W High: ₹668
52W Low: ₹278.2
Market Cap: ₹2,628 Cr

## Valuation
P/E: 8.93
P/B: 1.08
EPS: ₹41.81
Book Value: ₹346.08
Dividend Yield: 0%

## Returns
1Y Return: -22.08%

## Profitability
ROE: 0%
ROCE: 4.94%
Debt/Equity: 0.21
Revenue Growth: -2.2%
Profit Growth: 357.5%
EBITDA Margin: 9.5%
Operating Margin: 2.6%

## About
Unichem Laboratories Ltd is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Unichem Laboratories Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Quarterly Report: Board Meeting Intimation for To Consider And Approve The Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended March 31, 2026, And Audited Financial Results (Standalone And Consolidated) For The Year Ended March 31, 2026.
- Announcement: Announcement Under Reg. 30 - Product Recall
- BSE Filing: Announcement Under Reg. 30 - Product Recall

## Access
Current tier: anonymous
More history: Register free to see 13 more years.

## Data Freshness
Quote Updated: 2026-05-21T20:00:05.656Z
Price History Updated: 2026-05-18T22:58:50.640Z
Latest Price History Date: 2026-05-18
Technicals Updated: 2026-05-18T22:58:50.640Z
Quant Updated: 2026-05-18T22:58:50.640Z
Sentiment Updated: 2026-05-18T22:58:50.640Z
Financials Status: current
Financials Updated: 2026-05-19T11:30:27.081Z
Financials Last Attempt: 2026-05-19T11:30:27.081Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (FY25)
Revenue: ₹2064.48 Cr
Operating Profit: ₹140.3 Cr (OPM 6.8%)
Net Profit: ₹137.52 Cr
Tax: ₹17.07 Cr

## Annual P&L History
FY25: Rev ₹2064.48Cr | PAT ₹137.52Cr | OPM 6.8%
FY24: Rev ₹1737.63Cr | PAT ₹-93.76Cr | OPM -2.09%
FY23: Rev ₹1302.42Cr | PAT ₹-202.23Cr | OPM -11.95%

## Balance Sheet (FY25)
Total Assets: ₹3569.4 Cr
Total Liabilities: ₹1118.81 Cr
Borrowings: ₹459.77 Cr
Cash: ₹89.58 Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Pabitra Kumar Kalipada Bhattacharyya, MD & Director
- Sanjay  Jain, Chief Financial Officer
- Pradeep Kumar Bhandari, Head of Legal, Company Secretary & Compliance Officer
- Dhananjay  Sathe, Chief Scientific & Compliance Officer
- Prasad  Joshi, Vice President of Human Resources & ER

---
Source: rupiya.io/stocks/unichemlab
Disclaimer: For research and education only. Not investment advice.